AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $305,712 | -93.8% | 12,352 | -92.9% | 0.00% | -100.0% |
Q2 2023 | $4,927,822 | +347664.4% | 174,005 | +182.1% | 0.00% | +100.0% |
Q1 2023 | $1,417 | +236.6% | 61,689 | +311.3% | 0.00% | – |
Q4 2022 | $421 | -100.0% | 15,000 | -74.3% | 0.00% | -100.0% |
Q3 2022 | $1,652,000 | -39.8% | 58,421 | -52.8% | 0.00% | -50.0% |
Q2 2022 | $2,745,000 | +130.9% | 123,830 | +203.2% | 0.00% | +100.0% |
Q1 2022 | $1,189,000 | -59.9% | 40,835 | -54.7% | 0.00% | -50.0% |
Q4 2021 | $2,966,000 | +373.0% | 90,239 | +564.1% | 0.00% | – |
Q3 2021 | $627,000 | -95.1% | 13,588 | -94.5% | 0.00% | -100.0% |
Q1 2021 | $12,849,000 | -2.5% | 248,815 | -18.2% | 0.01% | 0.0% |
Q4 2020 | $13,184,000 | +383.5% | 304,265 | +290.6% | 0.01% | +233.3% |
Q3 2020 | $2,727,000 | -76.4% | 77,902 | -63.9% | 0.00% | -81.2% |
Q2 2020 | $11,539,000 | +17.0% | 215,752 | -22.4% | 0.02% | -27.3% |
Q1 2020 | $9,861,000 | -40.3% | 277,928 | -19.7% | 0.02% | +4.8% |
Q4 2019 | $16,531,000 | +77.1% | 346,203 | +20.2% | 0.02% | +40.0% |
Q3 2019 | $9,334,000 | +30.4% | 288,108 | +100.7% | 0.02% | +50.0% |
Q2 2019 | $7,160,000 | -28.1% | 143,542 | -33.5% | 0.01% | -37.5% |
Q4 2018 | $9,955,000 | +133.0% | 215,902 | +289.7% | 0.02% | +220.0% |
Q3 2018 | $4,273,000 | +95.1% | 55,409 | +47.7% | 0.01% | +25.0% |
Q1 2017 | $2,190,000 | -82.0% | 37,506 | -87.2% | 0.00% | -84.0% |
Q4 2016 | $12,199,000 | +164.7% | 292,310 | +235.1% | 0.02% | +212.5% |
Q3 2016 | $4,608,000 | +7.9% | 87,240 | -14.4% | 0.01% | -20.0% |
Q2 2016 | $4,269,000 | -87.9% | 101,901 | -88.2% | 0.01% | -88.6% |
Q1 2016 | $35,157,000 | +1206.5% | 865,939 | +1988.9% | 0.09% | +1366.7% |
Q4 2015 | $2,691,000 | -58.9% | 41,454 | -40.2% | 0.01% | -50.0% |
Q1 2015 | $6,541,000 | +393.7% | 69,363 | +221.1% | 0.01% | +300.0% |
Q3 2014 | $1,325,000 | -0.5% | 21,600 | -36.5% | 0.00% | -25.0% |
Q1 2014 | $1,331,000 | – | 34,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |